All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

FDA-&-EMA-New-Drug Approvals(Mid-2020 Recap)-insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Takeda Pharmaceutical

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

JAPAN Japan

Post An Enquiry

Chinaplas 2020

Participation Not Confirmed

Update your events

Johnson & Johnson Abandons Deal for Takeda's Tachosil Surgical Patch

Contact the Supplier

Lead Product(s): Human fibrinogen,Thrombin

Therapeutic Area: Hematology Product Name: Undisclosed

Highest Development Status: Approved Product Type: Large molecule

Partner/Sponsor/Collaborator: Johnson & Johnson

Deal Size: $400.0 million Upfront Cash: Undisclosed

Deal Type: Termination April 10, 2020

Details:

In late March, EU antitrust regulators had expressed concern about the deal and opened a full investigation into it.